$137 Million is the total value of HighVista Strategies LLC's 113 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PDLI | Exit | PDL BIOPHARMA INC | $0 | – | -12,700 | -100.0% | -0.03% | – |
| SACH | Exit | SACHEM CAP CORP | $0 | – | -12,500 | -100.0% | -0.03% | – |
| ATHX | Exit | ATHERSYS INC NEW | $0 | – | -18,800 | -100.0% | -0.04% | – |
| MNOV | Exit | MEDICINOVA INC | $0 | – | -11,700 | -100.0% | -0.05% | – |
| CPRX | Exit | CATALYST PHARMACEUTICALS INC | $0 | – | -15,800 | -100.0% | -0.06% | – |
| OSMT | Exit | OSMOTICA PHARMACEUTICALS PLC | $0 | – | -11,800 | -100.0% | -0.06% | – |
| PIRS | Exit | PIERIS PHARMACEUTICALS INC | $0 | – | -26,800 | -100.0% | -0.07% | – |
| MNKD | Exit | MANNKIND CORP | $0 | – | -48,600 | -100.0% | -0.07% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -15,000 | -100.0% | -0.09% | – |
| TSU | Exit | TIM PARTICIPACOES S Asponsored adr | $0 | – | -11,300 | -100.0% | -0.12% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | -11,800 | -100.0% | -0.13% | – |
| SI | Exit | SILVERGATE CAP CORPcl a | $0 | – | -13,579 | -100.0% | -0.16% | – |
| SCCO | Exit | SOUTHERN COPPER CORP | $0 | – | -6,600 | -100.0% | -0.22% | – |
| BCEL | Exit | ATRECA INC | $0 | – | -15,330 | -100.0% | -0.27% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -11,266 | -100.0% | -0.31% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -5,635 | -100.0% | -0.34% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -2,570 | -100.0% | -0.34% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -2,805 | -100.0% | -0.34% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -18,609 | -100.0% | -0.34% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -8,198 | -100.0% | -0.34% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -3,384 | -100.0% | -0.34% | – |
| KALA | Exit | KALA PHARMACEUTICALS INC | $0 | – | -39,943 | -100.0% | -0.35% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -5,396 | -100.0% | -0.35% | – |
| ALEC | Exit | ALECTOR INC | $0 | – | -17,352 | -100.0% | -0.35% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -247,059 | -100.0% | -0.35% | – |
| CDXS | Exit | CODEXIS INC | $0 | – | -38,009 | -100.0% | -0.36% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -2,549 | -100.0% | -0.36% | – |
| TCDA | Exit | TRICIDA INC | $0 | – | -16,235 | -100.0% | -0.37% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -14,467 | -100.0% | -0.40% | – |
| EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -10,596 | -100.0% | -0.42% | – |
| PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -9,165 | -100.0% | -0.45% | – |
| LOGM | Exit | LOGMEIN INC | $0 | – | -34,109 | -100.0% | -2.39% | – |
| CZR | Exit | CAESARS ENTMT CORP | $0 | – | -342,418 | -100.0% | -3.44% | – |
| TECD | Exit | TECH DATA CORP | $0 | – | -54,600 | -100.0% | -6.55% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSDIGM GROUP INC | 29 | Q2 2023 | 2.9% |
| VANGUARD INDEX FDS | 24 | Q4 2019 | 26.4% |
| APPLE INC | 24 | Q4 2019 | 2.0% |
| ISHARES TR | 22 | Q3 2018 | 7.9% |
| MICROSOFT CORP | 21 | Q3 2023 | 2.0% |
| VISA INC | 20 | Q3 2023 | 5.8% |
| INVESCO DB COMMDY INDX TRCK | 20 | Q3 2023 | 16.6% |
| VERIZON COMMUNICATIONS INC | 20 | Q4 2019 | 0.4% |
| ALIBABA GROUP HLDG LTD | 19 | Q3 2023 | 7.7% |
| AMAZON COM INC | 19 | Q3 2023 | 2.9% |
View HighVista Strategies LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STG Group, Inc.Sold out | February 16, 2016 | 0 | 0.0% |
| SAExploration Holdings, Inc. | February 12, 2014 | 25,000 | 0.2% |
| Trio Merger Corp. | February 14, 2013 | 690,000 | 8.8% |
View HighVista Strategies LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View HighVista Strategies LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.